Related references
Note: Only part of the references are listed.A review on Alzheimer's disease pathophysiology and its management: an update
Anil Kumar et al.
PHARMACOLOGICAL REPORTS (2015)
Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis
Chen-Chen Tan et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial
Niels D. Prins et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
A review on cholinesterase inhibitors for Alzheimer's disease
Preet Anand et al.
ARCHIVES OF PHARMACAL RESEARCH (2013)
Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis
Andrea C. Tricco et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2013)
Transdermal Is Better than Oral: Observational Research of the Satisfaction of Caregivers of Patients with Alzheimer's Disease Treated with Rivastigmine
Merce Boada et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2013)
Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer's disease
Michael W. Weiner et al.
ALZHEIMERS & DEMENTIA (2011)
Evidence for Ordering of Alzheimer Disease Biomarkers
Clifford R. Jack et al.
ARCHIVES OF NEUROLOGY (2011)
Mechanisms of Neuroprotective Effects of Nicotine and Acetylcholinesterase Inhibitors: Role of alpha 4 and alpha 7 Receptors in Neuroprotection
Akinori Akaike et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2010)
A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
Stefan Leucht et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine
R. Schmidt et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study
Howard H. Feldman et al.
LANCET NEUROLOGY (2007)
Preclinical evidence of neuroprotection by cholinesterase inhibitors
A Akaike
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2006)
Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease
KRR Krishnan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Impact of white matter changes on clinical manifestation of Alzheimer's disease - A quantitative study
N Hirono et al.
STROKE (2000)
Share Paper
